OptimizeRx OPRX Increase (Decrease) in Loans, Deferred Income
Increase (Decrease) in Loans, Deferred Income at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInLoansDeferredIncome.
The official record: OptimizeRx’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's increase (decrease) in loans, deferred income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's increase (decrease) in loans, deferred income?
- OptimizeRx (OPRX) reported increase (decrease) in loans, deferred income of $62.5K in Q4 2025.
- How has OptimizeRx's increase (decrease) in loans, deferred income changed year-over-year?
- OptimizeRx's increase (decrease) in loans, deferred income decreased by 0.0% year-over-year, from $62.5K to $62.5K.
- What does increase (decrease) in loans, deferred income mean?
- Measures the net movement in deferred income or loan-related liabilities that have not yet been recognized as revenue or settled. This captures cash received in advance of service delivery or changes in financing-related deferred obligations. It provides insight into the company's ability to generate cash ahead of performance obligations.